Table 3.
TRAEs | n (%) | Grade 1 n |
Grade 2 n |
Grade 3 n |
---|---|---|---|---|
Overall | 28 (35.9) | 8 | 14 | 6 |
Hypothyroidism | 5 (6.4) | 5 | ||
Pneumonia | 5 (6.4) | 3 | 1 | 1 |
Skin Toxicity | 5 (6.4) | 1 | 4 | |
Adrenal Insufficiency | 3 (3.8) | 3 | ||
Colitis/Diarrhea | 3 (3.8) | 2 | 1 | |
Stomatitis | 2 (2.6) | 1 | 1 | |
Liver Dysfunction | 2 (2.6) | 1 | 1 | |
Arthritis | 1 (1.3) | 1 | ||
Diabetes Mellitus | 1 (1.3) | 1 | ||
Renal Dysfunction | 1 (1.3) | 1 |
SCCHN, squamous cell carcinoma of the head and neck; TRAEs, treatment-related adverse events.